DE60324820D1 - Verfahren zum testen des oxidiertes-ldl-beta-2-glycoprotein-i-komplexes in vivo - Google Patents

Verfahren zum testen des oxidiertes-ldl-beta-2-glycoprotein-i-komplexes in vivo

Info

Publication number
DE60324820D1
DE60324820D1 DE60324820T DE60324820T DE60324820D1 DE 60324820 D1 DE60324820 D1 DE 60324820D1 DE 60324820 T DE60324820 T DE 60324820T DE 60324820 T DE60324820 T DE 60324820T DE 60324820 D1 DE60324820 D1 DE 60324820D1
Authority
DE
Germany
Prior art keywords
beta
complex
glycoprotein
vivo
testing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60324820T
Other languages
English (en)
Inventor
Eiji Matsuura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60324820D1 publication Critical patent/DE60324820D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60324820T 2002-09-06 2003-09-05 Verfahren zum testen des oxidiertes-ldl-beta-2-glycoprotein-i-komplexes in vivo Expired - Lifetime DE60324820D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002261366 2002-09-06
PCT/JP2003/011388 WO2004023141A1 (ja) 2002-09-06 2003-09-05 生体内の酸化LDL−β２−グリコプロテインⅠ複合体の測定方法

Publications (1)

Publication Number Publication Date
DE60324820D1 true DE60324820D1 (de) 2009-01-02

Family

ID=31973126

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60324820T Expired - Lifetime DE60324820D1 (de) 2002-09-06 2003-09-05 Verfahren zum testen des oxidiertes-ldl-beta-2-glycoprotein-i-komplexes in vivo

Country Status (7)

Country Link
US (1) US7455976B2 (de)
EP (1) EP1548436B1 (de)
JP (1) JP4280236B2 (de)
AT (1) ATE414904T1 (de)
AU (1) AU2003261976A1 (de)
DE (1) DE60324820D1 (de)
WO (1) WO2004023141A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2728473A1 (en) * 2008-06-20 2009-12-23 National University Corporation Okayama University Antibody against oxidized ldl/.beta.2gpi complex and use of the same
AU2010279249B2 (en) * 2009-02-06 2015-08-13 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
JP6399987B2 (ja) * 2015-09-11 2018-10-03 ヤマサ醤油株式会社 抗β２−ＧＰＩ抗体の測定法
US10858422B2 (en) 2016-05-31 2020-12-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
US10434141B2 (en) 2016-05-31 2019-10-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07306202A (ja) * 1992-04-01 1995-11-21 Maruzen Petrochem Co Ltd 細胞核ｄｎａの損傷検出方法
CA2172247A1 (en) * 1993-09-29 1995-04-06 Eiji Matsuura Method of assaying oxidized lipoprotein and application thereof

Also Published As

Publication number Publication date
JPWO2004023141A1 (ja) 2005-12-22
US20060099644A1 (en) 2006-05-11
EP1548436A1 (de) 2005-06-29
JP4280236B2 (ja) 2009-06-17
AU2003261976A1 (en) 2004-03-29
ATE414904T1 (de) 2008-12-15
WO2004023141A1 (ja) 2004-03-18
EP1548436A4 (de) 2006-09-20
US7455976B2 (en) 2008-11-25
EP1548436B1 (de) 2008-11-19

Similar Documents

Publication Publication Date Title
DE502006006367D1 (de) Verfahren zum messen einer analytkonzentration in
CY1110116T1 (el) Νευροεκφυλιστικοι δεικτες για καταθλιψη
WO2007002579A3 (en) Assay cartridges and methods for point of care instruments
EA201001397A1 (ru) Способ ультразвукового контроля испытуемого объекта
ATE443775T1 (de) Hif-prolylhydroxylase-aktivitätstest
EP1895303A4 (de) Verfahren zum testen eines blutbestandteils unter verwendung von vollblut sowie messkit
ATE421092T1 (de) Verwendung von gfap zum nachweis von intrazerebraler blutung
DE602005020446D1 (de) Konfokale flüssigkeitsstandmessung
WO2007000349A3 (en) Optical imaging of rheumatoid arthritis
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
EP2021794B8 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
ATE424143T1 (de) Verfahren und sensor zur messung der hautimpedanz
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
DE60324820D1 (de) Verfahren zum testen des oxidiertes-ldl-beta-2-glycoprotein-i-komplexes in vivo
WO2006066917A3 (en) Use of asc as a marker for colorectal cancer
DE60229303D1 (de) Bioäquivalenztest für eisenhaltige formulierungen
DE60310012D1 (de) Verfahren, Assay und Kit zur Quantifizierung von HIV-Proteasehemmer
EP1610127A4 (de) N1,n12-diacetylspermin als tumormarker
WO2009125936A3 (ko) 다낭성 난소 증후군 진단을 위한 분석방법 및 키트
WO2010000467A8 (en) Asc as a marker for lung cancer
ATE377655T1 (de) Verfahren zum messen von gesamt-homocystein
EP1987763A3 (de) System und Verfahren zum Messen und Anzeigen von Gesundheitsinformationen
WO2010043393A8 (en) Use of biglycan in the assessment of heart failure
DE50114111D1 (de) Elektrochemischer messfühler und verfahren zu dessen herstellung
DE50311968D1 (de) Sensor für einen elektrochemischen messfühler

Legal Events

Date Code Title Description
8364 No opposition during term of opposition